TP53 and urinary bladder carcinoma: Furthermore, the difference in incidence and type of TP53 mutations among the Iraqi TCC patients may explicitly indicate a distinct molecular pathway responsible for the development of bladder cancer due to exposure to environmental hazards (e.g. depleted uranium).